Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: A randomized, controlled trial

Transfusion

Volumn 49, Issue 12, 2009, Pages 2719-2728

  Goodnough, Lawrence Tim ^a,b,c,d,e,f   Van Wyck, David B ^a,b,c,d,e,f   Mangione, Antoinette ^a,b,c,d,e,f   Morrison, John ^a,b,c,d,e,f   Hadley, Phillip Earl ^a,b,c,d,e,f   Jehle, Judi A ^a,b,c,d,e,f  

^a DaVita Inc   (United States)

^b DAIICHI SANKYO CO   (Japan)

^c UNIVERSITY OF MISSISSIPPI   (United States)

^d Medical Network for Education and Research   (United States)

^e Obstetric Group   (United States)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CREATININE; FERRIC CARBOXYMALTOSE; FERRITIN; FERROUS SULFATE; HEMOGLOBIN; INJECTAFER; IRON DERIVATIVE; PHOSPHATE; POTASSIUM; TRANSFERRIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG ERUPTION; DRUG FATALITY; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; DYSGEUSIA; ERYTHROCYTE; ERYTHROPOIESIS; FATIGUE; FEMALE; FERRITIN BLOOD LEVEL; GASTROINTESTINAL SYMPTOM; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOPHOSPHATEMIA; HYPOTENSION; INJECTION SITE PAIN; IRON DEFICIENCY ANEMIA; IRON THERAPY; LEUKOCYTE COUNT; MACULOPAPULAR RASH; MAJOR CLINICAL STUDY; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; NAUSEA; OPEN STUDY; PATIENT COMPLIANCE; PERIPHERAL EDEMA; PHOSPHATE BLOOD LEVEL; PHYSICAL CAPACITY; POTASSIUM BLOOD LEVEL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RETICULOCYTE; SIDE EFFECT; THORAX PAIN; THROMBOCYTE; TREATMENT DURATION; TREATMENT OUTCOME; UTERUS BLEEDING; VOMITING;

ADMINISTRATION, ORAL; ADULT; ANEMIA, IRON-DEFICIENCY; CALCIUM; FEMALE; FERRIC COMPOUNDS; FERROUS COMPOUNDS; HEMATINICS; HEMOGLOBINS; HUMANS; INJECTIONS, INTRAVENOUS; MALTOSE; MIDDLE AGED; PHOSPHATES; POTASSIUM; QUALITY OF LIFE; TREATMENT OUTCOME; UTERINE HEMORRHAGE;

EID: 71849101678     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02327.x     Document Type: Article

References (30)

1. Cook JD, Flowers CH, Skikne BS. The quantitative assessment of body iron. Blood 2003 9 : 3359 64.
2. Centers for Disease Control and Prevention. Iron deficiency - United States, 1999-2000. MMWR Morb Mortal Wkly Rep 2002 51 : 897 9.
3. McClung JP, Marchitelli LJ, Friedl KE, Young AJ. Prevalence of iron deficiency and iron deficiency anemia among three populations of female military personnel in the US Army. J Am Coll Nutr 2006 25 : 64 9.
4. Cook JD, Skikne BS, Lynch SR, Reusser ME. Estimates of iron sufficiency in the U.S. population. Blood 1986 68 : 726 31.
5. Learman LA, Summitt RL Jr., Varner RE, Richter HE, Lin F, Ireland CC, Kuppermann M, Vittinghoff E, Showstack J, Washington AE, Hulley SB Medicine or Surgery Research Group. Hysterectomy versus expanded medical treatment for abnormal uterine bleeding: clinical outcomes in the medicine or surgery trial. Obstet Gynecol 2004 103 : 824 33. (Pubitemid 40458980)
6. Carlson KJ, Miller BA, Fowler FJ Jr. The Maine Women's Health Study: II. Outcomes of nonsurgical management of leiomyomas, abnormal bleeding, and chronic pelvic pain. Obstet Gynecol 1994 83 : 566 72.
7. Varner RE, Ireland CC, Summitt RL Jr., Richter HE, Learman LA, Vittinghoff E, Kuppermann M, Washington E, Hulley SB, for the Ms Research Group. Medicine or surgery (Ms): a randomized clinical trial comparing hysterectomy and medical treatment in premenopausal women with abnormal uterine bleeding. Control Clin Trials 2004 25 : 104 18. (Pubitemid 38230108)
8. Vercellini P, Vendola N, Ragni G, Trespidi L, Oldani S, Crosignani PG. Abnormal uterine bleeding associated with iron-deficiency anemia. Etiology and role of hysteroscopy. J Reprod Med 1993 38 : 502 4.
9. Crosby WH. The rationale for treating iron deficiency anemia. Arch Int Med 1984 144 : 471 2.
10. Hallberg L, Ryttinger L, Solvell L. Side-effects of oral iron therapy: a comparative trial of different iron compounds in tablet form. Acta Med Scand 1966 181 Suppl 459 : S3 10.
11. Bonnar J, Goldberg A, Smith JA. Do pregnant women take their iron? Lancet 1969 1 : 457 8.
12. Krafft A, Perewusnyk G, Hanseler E, Quack K, Huch R, Breymann C. Effect of postpartum iron supplementation on red cell and iron parameters in non-anaemic iron-deficient women: a randomised placebo-controlled study. BJOG 2005 112 : 445 50.
13. Walters BA, Van Wyck DB. Benchmarking iron dextran sensitivity: reactions requiring resuscitative medication in incident and prevalent patients. Nephrol Dial Transplant 2005 20 : 1438 42.
14. Van Wyck DB. Labile iron: manifestations and clinical implications. J Am Soc Nephrol 2004 15 Suppl 2 : S107 111.
15. Van Wyck DB, Martens MG, Seid MH, Baker JB, Mangione A. Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial. Obstet Gynecol 2007 110 : 267 78.
16. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005 352 : 43 55.
17. Ware JE, Kosinski M, Dewey JE. How to score version 2 of the SF-36® Health Survey. 3rd ed. Lincoln (RI) : QualityMetric, Inc 2001.
18. Portenoy RK. Fatigue: fatigue measurement. In : Max MB, Lynn J, editions. Interactive textbook of symptom research. Bethesda (MD) : National Institutes of Health 2006 cited 2007 Sep 8]. Available from: http://symptomresearch.nih. gov/chapter-9/sec6/crps6pg1.htm
19. Benagiano G, Kivinen ST, Fadini R, Cronje H, Klintorp S, van der Spuy ZM. Zoladex (goserelin acetate) and the anemic patient: results of a multicenter fibroid study. Fertil Steril 1996 66 : 223 9.
20. Larson B, Bremme K, Clyne N, Nordstrom L. Preoperative treatment of anemic women with epoetin beta. Acta Obstet Gynecol Scand 2001 80 : 559 62.
21. Goodnough LT, Bravo J, Hsueh Y, Keating L, Brittenham GM. Red blood cell volume in autologous and homologous blood units: implications for risk/benefit assessment for autologous blood "crossover" and directed blood donation. Transfusion 1989 29 : 821 2.
22. Centers for Disease Control and Prevention. Recommendations to prevent and control iron deficiency in the US. MMWR 1998 47 : 1 36.
23. US Census Bureau. Census 2000 Summary file 1, Table PCT12
24. Ware JE Jr., Bayliss MS, Rogers WH, Kosinski M, Tarlov AR. Differences in 4-year health outcomes for elderly and poor, chronically ill patients treated in HMO and fee-for-service systems. Results from the Medical Outcomes Study. J Am Med Assoc 1996 276 : 1039 47.
25. Beusterien KM, Nissenson AR, Port FK, Kelly M, Steinwald B, Ware JE. The effects of recombinant human erythropoietin on functional health and well-being in chronic dialysis patients. J Am Soc Nephrol 1996 7 : 763 73.
26. Leaf D, Goldfarb D. Interpretation and review of health-related quality of life data in CKD patients receiving treatment for anemia. Kidney Int 2009 75 : 15 24.
27. Foley R, Curtis B, Parfrey P. Erythropoietin therapy, hemoglobin targets, and quality of life in healthy hemodialysis patients: a randomized trial. Clin J Am Soc Nephrol 2009 4 : 726 33.
28. Mohammed S, Knoll S, van Amberg A, Mennes PA. Cefotetan-induced hemolytic anemia causing severe hypophosphatemia. Am J Hematol 1994 46 : 369 70.
29. Sahara N, Tamashima S, Ihara M Hereditary spherocytosis associated with severe hypophosphatemia in patients recovering from aplastic crisis Rinsho Ketsueki 1998 39 : 386 91.
30. Steiner M, Steiner B, Wilhelm S, Freund M, Schuff-Werner P. Severe hypophosphatemia during hematopoietic reconstitution after allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant 2000 25 : 1015 6.